Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Stream

 

Interview: Mike Wagner, Executive Director, The Advisory Board

We speak to Mike Wagner, executive director at healthcare consultancy The Advisory Board. Wagner believes there'll be a move towards a risk-segmented payor system that combines greater cost control for chronic patients and more service-oriented healthcare for the bulk of the population. Giving up old reservations and partnering with disruptive newcomers is key.

Carlyle to exit Concord

Private equity house Carlyle is exiting Chinese outsourcing group Concord Medical Services as management delists the company from the New York Stock Exchange. CEO Jianyu Yang's investment vehicle Morgancreek Investment and partner Blue Ocean Management will gain full ownership. They plan to expand the business to wholly owned cancer centres.

Diaverum enters China

Renal care provider Diaverum is entering China through a JV with state-owned conglomerate Yueda. The group is planning to build a network, initially in a handful of provinces including Jiangsu and Guangdong citing huge demand and decent public reimbursement schemes. We speak to Mans Olsson, Head of Middle East and Asia.

Universal health coverage and private health care: Friends or foes?

Universal Health Coverage is now explicitly targeted by the third sustainable development goal set out by the United Nations. Increasingly, governments around the world want to offer it to their citizenry. Where the capacity will come from is less certain. In this report, Healthcare Nova asks experts at the forefront of UHC schemes from India to Mexico, where UHC is today and what role the private sector should play in extending healthcare access to the poor?

Colombia’s statutory insurers on edge

Colombia's Minister of Health Alejandro Gaviria discussed the country's statutory insurance crisis at the private hospital association's 2016 ACHC Congress in Bogotá. Gaviria is wary of public subsidies to statutory insurers and rules out healthcare reform over the next couple of years. Instead, he argued, the system must draw on private funds to overcome liquidity problems.

Puzzles in Aster DM’s red herring prospectus

Middle East and Indian hospitals to pharmacy chain Aster DM’s red herring IPO prospectus begs as many questions as it answers. Why is EBITDA so low? Will its founder escape criminal charges? Why does it not include full financial year data? So how can it be worth 16,000 crores (an eye watering $2.4bn), that is more than Narayana and Fortis put together?

Chinese telehealth app raises US$183m

Chinese telehealth app Chunyu Yisheng raises RMB 1.2bn (US$183m) in a pre-IPO round, as the group is reported to list via a reverse takeover with an unnamed company. The news comes one month after insurer Ping An’s Doctor app, a similar product, completed a Series A funding round of $500m.

Einstein cuts costs

Retaining talent in hotelier hospitals and containing costs are two of private healthcare's main challenges in Latin America. Claudio Lottenberg, president of the Albert Einstein hospital in São Paulo, presented these challenges as two sides of the same coin at the Colombian private hospital association's 2016 ACHC Congress. Through engagement with physicians, Albert Einstein has achieved several milestones in cost control, quality and staff satisfaction, Lottenberg claimed.

Low-cost Indian ophthalmology chains expand

Two low-cost Indian ophthalmology chains are looking to expand. Based in central India, Eye-Q is opening five new facilities in the province of Maharashtra before going to Nigeria, while smaller group Dishtri aims to grow in the southern state of Karnataka.

Find Us